Management of nut allergy influences quality of life and anxiety in children and their mothers

Amanda J. Cummings, Rebecca C. Knibb, Michel Erlewyn-Lajeunesse, Rosemary M. King, Graham Roberts, Jane S.A. Lucas

Research output: Contribution to journalArticle

Abstract

Nut allergy is known to impact on the quality of life (QoL) and anxiety of both the allergic child and their parents, but little is known about how the management of food allergy is associated with these variables. To investigate the impact of nut allergy on QoL and anxiety in mothers and children with nut allergy in order to identify management strategies that may influence these factors. Forty-one nut allergic children (age 6–16 yrs) and their mothers completed questionnaires to assess maternal and children’s QoL (PedsQL™, WHOQOL-BREF, FAQL-PB), anxiety (SCAS, STAI) and perceived stress scale (PSS). Children also completed a nut allergy specific QoL questionnaire. Demographic data, details of previous reactions, test results and management plans were collected using parent-report questionnaires and hospital notes. Children with nut allergy had poorer emotional (p = 0.004), social (p = 0.043), and psychological (p = 0.006) QoL compared to healthy normative data. Maternal and child QoL and anxiety were not influenced by the severity of previous reactions. Mother and child reported lower anxiety (p = 0.043 and p < 0.001 respectively) when the child was prescribed an epinephrine auto-injector. Anxiety was not associated with whether the child carried the auto-injector or whether they strictly avoided traces of nuts in foods. Prescribing auto-injectors is associated with reduced anxiety for food allergic children and their mothers, but is not associated with improved adherence with medical management or reduced risk-taking behavior.
LanguageEnglish
Pages586-594
Number of pages9
JournalPaediatric Allergy and Immunology
Volume21
Issue number4
Early online date14 Jan 2010
DOIs
Publication statusPublished - Jun 2010

Fingerprint

Nut Hypersensitivity
Anxiety
Mothers
Quality of Life
Nuts
Food
Food Hypersensitivity
Risk-Taking

Keywords

  • peanut allergy management
  • quality of lif
  • anxiety

Cite this

Cummings, Amanda J. ; Knibb, Rebecca C. ; Erlewyn-Lajeunesse, Michel ; King, Rosemary M. ; Roberts, Graham ; Lucas, Jane S.A. / Management of nut allergy influences quality of life and anxiety in children and their mothers. In: Paediatric Allergy and Immunology. 2010 ; Vol. 21, No. 4. pp. 586-594.
@article{7b24a166a55e40ecbf60e85329f048fc,
title = "Management of nut allergy influences quality of life and anxiety in children and their mothers",
abstract = "Nut allergy is known to impact on the quality of life (QoL) and anxiety of both the allergic child and their parents, but little is known about how the management of food allergy is associated with these variables. To investigate the impact of nut allergy on QoL and anxiety in mothers and children with nut allergy in order to identify management strategies that may influence these factors. Forty-one nut allergic children (age 6–16 yrs) and their mothers completed questionnaires to assess maternal and children’s QoL (PedsQL™, WHOQOL-BREF, FAQL-PB), anxiety (SCAS, STAI) and perceived stress scale (PSS). Children also completed a nut allergy specific QoL questionnaire. Demographic data, details of previous reactions, test results and management plans were collected using parent-report questionnaires and hospital notes. Children with nut allergy had poorer emotional (p = 0.004), social (p = 0.043), and psychological (p = 0.006) QoL compared to healthy normative data. Maternal and child QoL and anxiety were not influenced by the severity of previous reactions. Mother and child reported lower anxiety (p = 0.043 and p < 0.001 respectively) when the child was prescribed an epinephrine auto-injector. Anxiety was not associated with whether the child carried the auto-injector or whether they strictly avoided traces of nuts in foods. Prescribing auto-injectors is associated with reduced anxiety for food allergic children and their mothers, but is not associated with improved adherence with medical management or reduced risk-taking behavior.",
keywords = "peanut allergy management, quality of lif, anxiety",
author = "Cummings, {Amanda J.} and Knibb, {Rebecca C.} and Michel Erlewyn-Lajeunesse and King, {Rosemary M.} and Graham Roberts and Lucas, {Jane S.A.}",
year = "2010",
month = "6",
doi = "10.1111/j.1399-3038.2009.00975.x",
language = "English",
volume = "21",
pages = "586--594",
journal = "Paediatric Allergy and Immunology",
issn = "0905-6157",
publisher = "Blackwell",
number = "4",

}

Management of nut allergy influences quality of life and anxiety in children and their mothers. / Cummings, Amanda J.; Knibb, Rebecca C.; Erlewyn-Lajeunesse, Michel; King, Rosemary M.; Roberts, Graham; Lucas, Jane S.A.

In: Paediatric Allergy and Immunology, Vol. 21, No. 4, 06.2010, p. 586-594.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Management of nut allergy influences quality of life and anxiety in children and their mothers

AU - Cummings, Amanda J.

AU - Knibb, Rebecca C.

AU - Erlewyn-Lajeunesse, Michel

AU - King, Rosemary M.

AU - Roberts, Graham

AU - Lucas, Jane S.A.

PY - 2010/6

Y1 - 2010/6

N2 - Nut allergy is known to impact on the quality of life (QoL) and anxiety of both the allergic child and their parents, but little is known about how the management of food allergy is associated with these variables. To investigate the impact of nut allergy on QoL and anxiety in mothers and children with nut allergy in order to identify management strategies that may influence these factors. Forty-one nut allergic children (age 6–16 yrs) and their mothers completed questionnaires to assess maternal and children’s QoL (PedsQL™, WHOQOL-BREF, FAQL-PB), anxiety (SCAS, STAI) and perceived stress scale (PSS). Children also completed a nut allergy specific QoL questionnaire. Demographic data, details of previous reactions, test results and management plans were collected using parent-report questionnaires and hospital notes. Children with nut allergy had poorer emotional (p = 0.004), social (p = 0.043), and psychological (p = 0.006) QoL compared to healthy normative data. Maternal and child QoL and anxiety were not influenced by the severity of previous reactions. Mother and child reported lower anxiety (p = 0.043 and p < 0.001 respectively) when the child was prescribed an epinephrine auto-injector. Anxiety was not associated with whether the child carried the auto-injector or whether they strictly avoided traces of nuts in foods. Prescribing auto-injectors is associated with reduced anxiety for food allergic children and their mothers, but is not associated with improved adherence with medical management or reduced risk-taking behavior.

AB - Nut allergy is known to impact on the quality of life (QoL) and anxiety of both the allergic child and their parents, but little is known about how the management of food allergy is associated with these variables. To investigate the impact of nut allergy on QoL and anxiety in mothers and children with nut allergy in order to identify management strategies that may influence these factors. Forty-one nut allergic children (age 6–16 yrs) and their mothers completed questionnaires to assess maternal and children’s QoL (PedsQL™, WHOQOL-BREF, FAQL-PB), anxiety (SCAS, STAI) and perceived stress scale (PSS). Children also completed a nut allergy specific QoL questionnaire. Demographic data, details of previous reactions, test results and management plans were collected using parent-report questionnaires and hospital notes. Children with nut allergy had poorer emotional (p = 0.004), social (p = 0.043), and psychological (p = 0.006) QoL compared to healthy normative data. Maternal and child QoL and anxiety were not influenced by the severity of previous reactions. Mother and child reported lower anxiety (p = 0.043 and p < 0.001 respectively) when the child was prescribed an epinephrine auto-injector. Anxiety was not associated with whether the child carried the auto-injector or whether they strictly avoided traces of nuts in foods. Prescribing auto-injectors is associated with reduced anxiety for food allergic children and their mothers, but is not associated with improved adherence with medical management or reduced risk-taking behavior.

KW - peanut allergy management

KW - quality of lif

KW - anxiety

UR - http://www.scopus.com/inward/record.url?scp=77953318215&partnerID=8YFLogxK

UR - http://onlinelibrary.wiley.com/doi/10.1111/j.1399-3038.2009.00975.x/abstract

U2 - 10.1111/j.1399-3038.2009.00975.x

DO - 10.1111/j.1399-3038.2009.00975.x

M3 - Article

VL - 21

SP - 586

EP - 594

JO - Paediatric Allergy and Immunology

T2 - Paediatric Allergy and Immunology

JF - Paediatric Allergy and Immunology

SN - 0905-6157

IS - 4

ER -